Search is Powered by Google
HIV / AIDS News

Swaziland To Purchase Antiretrovirals From Uganda To Address Country's HIV/AIDS Epidemic, King Mswati Says

Main Category: HIV / AIDS
Article Date: 14 Jul 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Swazi King Mswati III on Tuesday during his four-day tour of Uganda said that Swaziland plans to purchase antiretroviral drugs from a Ugandan factory to address the country's HIV/AIDS epidemic, Africa Science News Service reports. In Swaziland, more than 30% of the country's 1.2 million people are HIV-positive, the highest HIV prevalence rate in the world (Africa Science News Service, 7/9).

Mswati on Tuesday toured a new factory in Kampala, Uganda, that produces drugs for HIV/AIDS and malaria, the New Vision/AllAfrica.com reports. Swazi Foreign Affairs Minister Moses Mathedelene said the Swazi government initially plans to purchase antiretrovirals from Uganda when the factory starts full production. "This visit is part of our efforts to curb the HIV epidemic," Mathedelene said, adding that Swaziland plans to "build a factory of a similar nature." During the tour of the factory, Mswati witnessed the production process for antiretroviral and malaria drugs, as well as the packaging process. He also learned about the establishment of the factory, its production capacity and rates of return, the New Vision/AllAfrica.com reports.

Also present was Ugandan President Yoweri Museveni, Uganda Minister of Health Stephen Mallinga, Information and Communications Technology Minister Ham Mulira and other officials. Museveni said Uganda plans to purchase shares in the factory worth 10 billion Ugandan shillings, or about $6.1 million, in order to enhance production of drugs in the country (Among, New Vision/AllAfrica.com, 7/9). Francis Kitaka, chair of the board of directors for the pharmaceutical company Quality Chemical, said that the plan will reach full production capacity in August and that it will be able to produce six million HIV/AIDS and malaria drugs daily (Africa Science News Service, 7/9).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Keeping a Personal Medical Record image Keeping a Personal Medical Record

Medical information is usually scattered in many different places. To receive the best possible health care, people are encouraged to gather information in one place and create a personal medical record...

View more videos...